{"id":"https://openalex.org/W2164868034","doi":"https://doi.org/10.1158/1535-7163.mct-12-1045","title":"Potential Advantages of CUDC-101, a Multitargeted HDAC, EGFR, and HER2 Inhibitor, in Treating Drug Resistance and Preventing Cancer Cell Migration and Invasion","display_name":"Potential Advantages of CUDC-101, a Multitargeted HDAC, EGFR, and HER2 Inhibitor, in Treating Drug Resistance and Preventing Cancer Cell Migration and Invasion","publication_year":2013,"publication_date":"2013-03-28","ids":{"openalex":"https://openalex.org/W2164868034","doi":"https://doi.org/10.1158/1535-7163.mct-12-1045","mag":"2164868034","pmid":"https://pubmed.ncbi.nlm.nih.gov/23536719"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-12-1045","doi":"https://doi.org/10.1158/1535-7163.mct-12-1045","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-12-1045","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100378656","display_name":"Jing Wang","orcid":"https://orcid.org/0000-0003-1580-1356","observed_orcids":["https://orcid.org/0000-0003-1580-1356","https://orcid.org/0009-0009-7012-5216","https://orcid.org/0000-0002-1980-539X"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210140335","display_name":"Institut de Recherche en Canc\u00e9rologie de Montpellier","ror":"https://ror.org/03capj968","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I19894307","https://openalex.org/I4210140335","https://openalex.org/I4210141925","https://openalex.org/I4387154388"]},{"id":"https://openalex.org/I4387153574","display_name":"Universit\u00e9 Montpellier 1","ror":"https://ror.org/0227fbx80","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307","https://openalex.org/I4387153574"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jing Wang","raw_affiliation_strings":["Authors' Affiliations:\u20081Curis, Inc. Lexington, Massachusetts; and 2Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM), U896, Universit\u00e9 Montpellier I, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Curis, Inc. Lexington, Massachusetts; and 2Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM), U896, Universit\u00e9 Montpellier I, Montpellier, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210140335","https://openalex.org/I4387153574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091117919","display_name":"Natalie W. Pursell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210140335","display_name":"Institut de Recherche en Canc\u00e9rologie de Montpellier","ror":"https://ror.org/03capj968","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I19894307","https://openalex.org/I4210140335","https://openalex.org/I4210141925","https://openalex.org/I4387154388"]},{"id":"https://openalex.org/I4387153574","display_name":"Universit\u00e9 Montpellier 1","ror":"https://ror.org/0227fbx80","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307","https://openalex.org/I4387153574"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Natalie W. Pursell","raw_affiliation_strings":["Authors' Affiliations:\u20081Curis, Inc. Lexington, Massachusetts; and 2Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM), U896, Universit\u00e9 Montpellier I, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Curis, Inc. Lexington, Massachusetts; and 2Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM), U896, Universit\u00e9 Montpellier I, Montpellier, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210140335","https://openalex.org/I4387153574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110461270","display_name":"Maria Samson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210140335","display_name":"Institut de Recherche en Canc\u00e9rologie de Montpellier","ror":"https://ror.org/03capj968","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I19894307","https://openalex.org/I4210140335","https://openalex.org/I4210141925","https://openalex.org/I4387154388"]},{"id":"https://openalex.org/I4387153574","display_name":"Universit\u00e9 Montpellier 1","ror":"https://ror.org/0227fbx80","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307","https://openalex.org/I4387153574"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Maria Elena S. Samson","raw_affiliation_strings":["Authors' Affiliations:\u20081Curis, Inc. Lexington, Massachusetts; and 2Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM), U896, Universit\u00e9 Montpellier I, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Curis, Inc. Lexington, Massachusetts; and 2Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM), U896, Universit\u00e9 Montpellier I, Montpellier, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210140335","https://openalex.org/I4387153574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065104224","display_name":"Ruzanna Atoyan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210140335","display_name":"Institut de Recherche en Canc\u00e9rologie de Montpellier","ror":"https://ror.org/03capj968","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I19894307","https://openalex.org/I4210140335","https://openalex.org/I4210141925","https://openalex.org/I4387154388"]},{"id":"https://openalex.org/I4387153574","display_name":"Universit\u00e9 Montpellier 1","ror":"https://ror.org/0227fbx80","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307","https://openalex.org/I4387153574"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Ruzanna Atoyan","raw_affiliation_strings":["Authors' Affiliations:\u20081Curis, Inc. Lexington, Massachusetts; and 2Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM), U896, Universit\u00e9 Montpellier I, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Curis, Inc. Lexington, Massachusetts; and 2Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM), U896, Universit\u00e9 Montpellier I, Montpellier, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210140335","https://openalex.org/I4387153574"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Anna W. Ma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210140335","display_name":"Institut de Recherche en Canc\u00e9rologie de Montpellier","ror":"https://ror.org/03capj968","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I19894307","https://openalex.org/I4210140335","https://openalex.org/I4210141925","https://openalex.org/I4387154388"]},{"id":"https://openalex.org/I4387153574","display_name":"Universit\u00e9 Montpellier 1","ror":"https://ror.org/0227fbx80","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307","https://openalex.org/I4387153574"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Anna W. Ma","raw_affiliation_strings":["Authors' Affiliations:\u20081Curis, Inc. Lexington, Massachusetts; and 2Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM), U896, Universit\u00e9 Montpellier I, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Curis, Inc. Lexington, Massachusetts; and 2Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM), U896, Universit\u00e9 Montpellier I, Montpellier, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210140335","https://openalex.org/I4387153574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039372671","display_name":"Abdelkader Selmi","orcid":"https://orcid.org/0000-0001-5760-0507","observed_orcids":["https://orcid.org/0000-0001-5760-0507"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210140335","display_name":"Institut de Recherche en Canc\u00e9rologie de Montpellier","ror":"https://ror.org/03capj968","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I19894307","https://openalex.org/I4210140335","https://openalex.org/I4210141925","https://openalex.org/I4387154388"]},{"id":"https://openalex.org/I4387153574","display_name":"Universit\u00e9 Montpellier 1","ror":"https://ror.org/0227fbx80","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307","https://openalex.org/I4387153574"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Abdelkader Selmi","raw_affiliation_strings":["Authors' Affiliations:\u20081Curis, Inc. Lexington, Massachusetts; and 2Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM), U896, Universit\u00e9 Montpellier I, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Curis, Inc. Lexington, Massachusetts; and 2Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM), U896, Universit\u00e9 Montpellier I, Montpellier, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210140335","https://openalex.org/I4387153574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071635528","display_name":"Wanlu Xu","orcid":"https://orcid.org/0000-0002-8838-9879","observed_orcids":["https://orcid.org/0000-0002-8838-9879"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210140335","display_name":"Institut de Recherche en Canc\u00e9rologie de Montpellier","ror":"https://ror.org/03capj968","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I19894307","https://openalex.org/I4210140335","https://openalex.org/I4210141925","https://openalex.org/I4387154388"]},{"id":"https://openalex.org/I4387153574","display_name":"Universit\u00e9 Montpellier 1","ror":"https://ror.org/0227fbx80","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307","https://openalex.org/I4387153574"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Wanlu Xu","raw_affiliation_strings":["Authors' Affiliations:\u20081Curis, Inc. Lexington, Massachusetts; and 2Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM), U896, Universit\u00e9 Montpellier I, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Curis, Inc. Lexington, Massachusetts; and 2Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM), U896, Universit\u00e9 Montpellier I, Montpellier, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210140335","https://openalex.org/I4387153574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031922950","display_name":"Xiong Cai","orcid":"https://orcid.org/0000-0002-8721-5586","observed_orcids":["https://orcid.org/0000-0002-8721-5586"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210140335","display_name":"Institut de Recherche en Canc\u00e9rologie de Montpellier","ror":"https://ror.org/03capj968","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I19894307","https://openalex.org/I4210140335","https://openalex.org/I4210141925","https://openalex.org/I4387154388"]},{"id":"https://openalex.org/I4387153574","display_name":"Universit\u00e9 Montpellier 1","ror":"https://ror.org/0227fbx80","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307","https://openalex.org/I4387153574"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Xiong Cai","raw_affiliation_strings":["Authors' Affiliations:\u20081Curis, Inc. Lexington, Massachusetts; and 2Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM), U896, Universit\u00e9 Montpellier I, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Curis, Inc. Lexington, Massachusetts; and 2Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM), U896, Universit\u00e9 Montpellier I, Montpellier, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210140335","https://openalex.org/I4387153574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079238859","display_name":"Maurizio Voi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210140335","display_name":"Institut de Recherche en Canc\u00e9rologie de Montpellier","ror":"https://ror.org/03capj968","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I19894307","https://openalex.org/I4210140335","https://openalex.org/I4210141925","https://openalex.org/I4387154388"]},{"id":"https://openalex.org/I4387153574","display_name":"Universit\u00e9 Montpellier 1","ror":"https://ror.org/0227fbx80","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307","https://openalex.org/I4387153574"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Maurizio Voi","raw_affiliation_strings":["Authors' Affiliations:\u20081Curis, Inc. Lexington, Massachusetts; and 2Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM), U896, Universit\u00e9 Montpellier I, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Curis, Inc. Lexington, Massachusetts; and 2Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM), U896, Universit\u00e9 Montpellier I, Montpellier, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210140335","https://openalex.org/I4387153574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002455905","display_name":"Pierre Savagner","orcid":"https://orcid.org/0000-0002-8287-2229","observed_orcids":["https://orcid.org/0000-0002-8287-2229"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210140335","display_name":"Institut de Recherche en Canc\u00e9rologie de Montpellier","ror":"https://ror.org/03capj968","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I19894307","https://openalex.org/I4210140335","https://openalex.org/I4210141925","https://openalex.org/I4387154388"]},{"id":"https://openalex.org/I4387153574","display_name":"Universit\u00e9 Montpellier 1","ror":"https://ror.org/0227fbx80","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307","https://openalex.org/I4387153574"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Pierre Savagner","raw_affiliation_strings":["Authors' Affiliations:\u20081Curis, Inc. Lexington, Massachusetts; and 2Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM), U896, Universit\u00e9 Montpellier I, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Curis, Inc. Lexington, Massachusetts; and 2Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM), U896, Universit\u00e9 Montpellier I, Montpellier, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210140335","https://openalex.org/I4387153574"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018703558","display_name":"Cheng-Jung Lai","orcid":"https://orcid.org/0000-0002-3321-8984","observed_orcids":["https://orcid.org/0000-0002-3321-8984"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210140335","display_name":"Institut de Recherche en Canc\u00e9rologie de Montpellier","ror":"https://ror.org/03capj968","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I19894307","https://openalex.org/I4210140335","https://openalex.org/I4210141925","https://openalex.org/I4387154388"]},{"id":"https://openalex.org/I4387153574","display_name":"Universit\u00e9 Montpellier 1","ror":"https://ror.org/0227fbx80","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307","https://openalex.org/I4387153574"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Cheng-Jung Lai","raw_affiliation_strings":["Authors' Affiliations:\u20081Curis, Inc. Lexington, Massachusetts; and 2Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM), U896, Universit\u00e9 Montpellier I, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Curis, Inc. Lexington, Massachusetts; and 2Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Institut National de la Sant\u00e9 et de la Recherche Medicale (INSERM), U896, Universit\u00e9 Montpellier I, Montpellier, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210140335","https://openalex.org/I4387153574"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.4659,"has_fulltext":false,"cited_by_count":81,"citation_normalized_percentile":{"value":0.95700182,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"12","issue":"6","first_page":"925","last_page":"936"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.3977000117301941,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.3977000117301941,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.3630000054836273,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.1858000010251999,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cudc-101","display_name":"CUDC-101","score":1.0},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.8650000095367432},{"id":"https://openalex.org/keywords/egfr-inhibitors","display_name":"EGFR inhibitors","score":0.9670000076293945},{"id":"https://openalex.org/keywords/her2-inhibitors","display_name":"HER2 inhibitors","score":0.9829999804496765},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7509999871253967},{"id":"https://openalex.org/keywords/axl","display_name":"AXL","score":0.6169999837875366},{"id":"https://openalex.org/keywords/met","display_name":"MET","score":0.7519999742507935},{"id":"https://openalex.org/keywords/e-cadherin","display_name":"E-cadherin","score":0.9959999918937683},{"id":"https://openalex.org/keywords/tumor-cell-migration","display_name":"tumor cell migration","score":0.8870000243186951},{"id":"https://openalex.org/keywords/tumor-invasion","display_name":"tumor invasion","score":0.9210000038146973},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9890000224113464},{"id":"https://openalex.org/keywords/gastric-cancer","display_name":"gastric cancer","score":0.9819999933242798}],"concepts":[{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.6825181245803833},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.6309086084365845},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.610275387763977},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5992181301116943},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5530272722244263},{"id":"https://openalex.org/C2776202225","wikidata":"https://www.wikidata.org/wiki/Q3569101","display_name":"Histone deacetylase inhibitor","level":5,"score":0.4603199362754822},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.42591696977615356},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.42071861028671265},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.4185430407524109},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34882837533950806},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2407841980457306},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.1499236524105072},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.13320305943489075},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.06416192650794983},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069347","descriptor_name":"Erlotinib Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002465","descriptor_name":"Cell Movement","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006655","descriptor_name":"Histone Deacetylases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006877","descriptor_name":"Hydroxamic Acids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D009361","descriptor_name":"Neoplasm Invasiveness","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009361","descriptor_name":"Neoplasm Invasiveness","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D013274","descriptor_name":"Stomach Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013274","descriptor_name":"Stomach Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013274","descriptor_name":"Stomach Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015820","descriptor_name":"Cadherins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019859","descriptor_name":"Proto-Oncogene Proteins c-met","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056572","descriptor_name":"Histone Deacetylase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.mct-12-1045","doi":"https://doi.org/10.1158/1535-7163.mct-12-1045","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-12-1045","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:23536719","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23536719","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9789000153541565,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":53,"referenced_works":["https://openalex.org/W237746977","https://openalex.org/W1505984895","https://openalex.org/W1607701774","https://openalex.org/W1964212105","https://openalex.org/W1968442009","https://openalex.org/W1978270921","https://openalex.org/W1980497534","https://openalex.org/W1983774108","https://openalex.org/W1987848307","https://openalex.org/W1996275566","https://openalex.org/W1998971866","https://openalex.org/W1999563934","https://openalex.org/W2000889184","https://openalex.org/W2003526392","https://openalex.org/W2007927573","https://openalex.org/W2011060185","https://openalex.org/W2013022837","https://openalex.org/W2019443090","https://openalex.org/W2038056960","https://openalex.org/W2043696829","https://openalex.org/W2049484790","https://openalex.org/W2069421644","https://openalex.org/W2073100055","https://openalex.org/W2074242691","https://openalex.org/W2078134150","https://openalex.org/W2079750277","https://openalex.org/W2092643288","https://openalex.org/W2093384992","https://openalex.org/W2093613683","https://openalex.org/W2102411854","https://openalex.org/W2106326323","https://openalex.org/W2111955159","https://openalex.org/W2116822103","https://openalex.org/W2118661220","https://openalex.org/W2119351872","https://openalex.org/W2120718661","https://openalex.org/W2122895515","https://openalex.org/W2129110050","https://openalex.org/W2130461015","https://openalex.org/W2138709542","https://openalex.org/W2139236349","https://openalex.org/W2140407529","https://openalex.org/W2140752599","https://openalex.org/W2141542227","https://openalex.org/W2146012957","https://openalex.org/W2146404049","https://openalex.org/W2150416393","https://openalex.org/W2151808807","https://openalex.org/W2161821474","https://openalex.org/W2167620731","https://openalex.org/W2264655007","https://openalex.org/W2326889571","https://openalex.org/W6682415940"],"related_works":["https://openalex.org/W2058961982","https://openalex.org/W2118661220","https://openalex.org/W2314812170","https://openalex.org/W2116219814","https://openalex.org/W2068473772","https://openalex.org/W2322593713","https://openalex.org/W2129594020","https://openalex.org/W4234437619","https://openalex.org/W2982022466","https://openalex.org/W4388529466"],"abstract_inverted_index":{"CUDC-101":[0,33,88],"is":[1,17],"a":[2],"novel,":[3],"small-molecule,":[4],"anticancer":[5],"agent":[6],"targeting":[7],"histone":[8],"deacetylase":[9],"(HDAC),":[10],"EGF":[11],"receptor":[12],"(EGFR),":[13],"and":[14,37,44,78,84,100,105,109,123,139],"HER2.":[15],"It":[16],"currently":[18],"in":[19,24,40,45,135],"phase":[20],"I":[21],"clinical":[22],"development":[23],"patients":[25],"with":[26],"solid":[27],"tumors.":[28],"Previously,":[29],"we":[30],"reported":[31],"that":[32,52,55,120],"has":[34],"potent":[35],"antiproliferative":[36],"proapoptotic":[38],"activity":[39],"cultured":[41],"tumor":[42,113],"cells":[43,54],"vivo":[46],"xenograft":[47],"models.":[48],"We":[49],"now":[50],"show":[51],"cancer":[53,99,102,141],"have":[56],"acquired":[57],"resistance":[58,138],"to":[59,73,127],"single-target":[60],"EGFR":[61,129],"inhibitors":[62],"through":[63],"upregulation":[64],"of":[65,69,94,111],"AXL":[66],"or":[67],"loss":[68],"E-cadherin":[70,82],"remain":[71],"sensitive":[72],"CUDC-101,":[74],"which":[75],"inhibits":[76],"MET-":[77],"AXL-mediated":[79],"signaling,":[80],"restores":[81],"expression,":[83],"reduces":[85],"cell":[86,97,103,142],"migration.":[87,143],"also":[89],"efficiently":[90],"inhibited":[91,106],"the":[92,107],"proliferation":[93],"MET-overexpressing":[95],"non-small":[96],"lung":[98],"gastric":[101],"lines":[104],"migration":[108],"invasion":[110],"invasive":[112],"cells.":[114],"Taken":[115],"together,":[116],"these":[117],"results":[118],"suggest":[119],"coupling":[121],"HDAC":[122],"HER2":[124],"inhibitory":[125],"activities":[126],"an":[128],"inhibitor":[130],"may":[131],"potentially":[132],"be":[133],"effective":[134],"overcoming":[136],"drug":[137],"preventing":[140]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}